Study Stopped
Lack of enrollment
Using CPAP to Improve Menstruation in Women With Polycystic Ovarian Syndrome and Obstructive Sleep Apnea
A Novel Method of Restoring Menstrual Cyclicity or Ovulatory Function in PCOS Patients: The Use of CPAP to Improve More Than Sleep Quality
1 other identifier
observational
N/A
1 country
1
Brief Summary
The purpose of this study is to determine if treatment of obstructive sleep apnea (OSA) with continuous positive airway pressure in women with both OSA and polycystic ovarian syndrome will improve the regularity of the women's menstrual cycles.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jul 2016
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2016
CompletedFirst Submitted
Initial submission to the registry
May 11, 2017
CompletedFirst Posted
Study publicly available on registry
May 16, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2018
CompletedAugust 3, 2018
August 1, 2018
2.1 years
May 11, 2017
August 1, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Menstrual Cyclicity
Resumption of regular cycles as evaluated either by paper menstrual calendar or use of a menstrual cycle application on smart phone or tablet.
6 months
Secondary Outcomes (1)
Ovulation
6 months
Interventions
Women with diagnosed obstructive sleep apnea will be treated using continuous positive airway pressure as per standard of care.
Eligibility Criteria
Women seeking fertility treatment at the University of Louisville Reproductive Endocrinology and Infertility Center who have diagnosed polycystic ovarian syndrome, glucose intolerance, obesity, and obstructive sleep apnea.
You may qualify if:
- Age 18-35
- English speakers
- Polycystic ovarian syndrome by NIH criteria
- Abnormal 2 hour glucose tolerance test
- Body mass index \>/= 40 kg/m2
- Severe obstructive sleep apnea diagnosed with either a home or in-house sleep study
You may not qualify if:
- Age \<18 or \>35
- Non English speakers
- No diagnosis of PCOS
- Normal glucose tolerance test
- No diagnosis of obstructive sleep apnea
- Body mass index \< 40 kg/m2
- Using any form of hormonal contraception
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Louisville Fertility Center
Louisville, Kentucky, 40205, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kelly Pagidas, MD
University of Louisville
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Obstetrics and Gynecology and Women's Health
Study Record Dates
First Submitted
May 11, 2017
First Posted
May 16, 2017
Study Start
July 1, 2016
Primary Completion
August 1, 2018
Study Completion
August 1, 2018
Last Updated
August 3, 2018
Record last verified: 2018-08
Data Sharing
- IPD Sharing
- Will not share